Events

UConn Health Celebrates 25 Years of ADA

Antczak-Bouckoms
Dr. Alexia Antczak-Bouckoms, UConn dental faculty member and former student, observes the speaking program at UConn Health’s celebration of the Americans with Disabilities Act. (Janine Gelineau/UConn Health)

To Dr. Alexia Antczak-Bouckoms, who graduated from the UConn School of Dental Medicine in 1979, the letters “ADA” always stood for American Dental Association.

That was until 1996, when she was injured in accident that has confined her to a wheelchair. Since then, ADA has had a second meaning.

The Americans with Disabilities Act was signed into law by President George H.W. Bush July 26, 1990. Friday the UConn Center for Excellence in Developmental Disabilities held a celebration to commemorate that milestone in American civil rights.

Antczak-Bouckoms, who’s now on the UConn dental faculty, was among the dozens of advocates for the disabled who were on hand to acknowledge the difference the ADA has made over the last 25 years.

“I think it’s done a wonderful job,” Antczak-Bouckoms says. “I think we need to think about ADA-plus, how we can make it better, and build on the strengths of it, make people’s ability to participate in society more seamless.”

Cathy Ludlum, a writer and disability advocate who lives independently with a disability, remembers what life was like before the ADA, including being carried in and out of buildings, cars and planes.

Bruder-Ludlum
UCEDD Director Mary Beth Bruder and Cathy Ludlum, advocate for the disabled, discuss the Americans with Disabilities Act at a ceremony for the 25th anniversary of the ADA’s signing. (Janine Gelineau/UConn Health)

“I don’t think anything was accessible. Even if there were buildings without stairs, the doors were too narrow,” Ludlum says. “Accessible transportation was unheard of. It may not be perfect yet, but in those days it was nonexistent. Nobody had a wheelchair-accessible van, and certainly there were no accessible buses or taxis.”

Ludlum recalls not being able to attend her local elementary school because it wasn’t accessible, and how she was told by a prospective employer that a simple accommodation couldn’t be made for her.

“The ADA is as much for people who do not have disabilities as it is for those with disabilities,” says UCEDD Director Mary Beth Bruder. “We all benefit when our government reinforces our equal rights under law. Most importantly, we all benefit when we are able to live and learn and become friends with those who have disabilities who are now able to be full members of the communities in which they live, in part because of the ADA.” The human race has a range of people with strengths and gifts and challenges and we should recognize and celebrate our diversity as we help each other through life. It’s just a perspective, but I believe the ADA enriches all of us and reinforces our collective responsibility to our human race.”

McGaughey, Elling
Professor Emeritus Ray Elling (right), founding member of the UConn School of Medicine faculty, and disability policy specialist Jim McGaughey, are among the advocates for the disabled who spoke at the Americans with Disabilities Act 25th anniversary celebration at UConn Health. (Janine Gelineau/UConn Health)

Also present was Professor Emeritus Ray Elling, a founding member of the UConn School of Medicine faculty, who has led efforts to fund a requirement that all federally funded buildings be built with automatic doors. He says it appears to be gaining support in Congress.

“We’ve got a lot to do,” Elling says. “Let’s get the doors open for everyone, and let’s do it now.”

As for Antczak-Bouckoms, she teaches second-year medical and dental students about caring for and relating to patients with disabilities.

She’s also getting ready to roll in her third New York City Marathon this fall.

“That’s been a spiritual experience, going through the five boroughs without a roof over your head to raise money for spinal cord research, it’s just amazing,” Antczak-Bouckoms says.

She’s also completed the Hartford Half Marathon six times.

U.S. Sen. Richard Blumenthal Visits UConn Health

U.S. Sen. Richard Blumenthal speaking to Anne Diamond Chief Executive Officer, John Dempsey Hospital, and Dr. Pramod Srivastava during his recent visit to UConn Health.
U.S. Sen. Richard Blumenthal speaking to Anne Diamond,
Chief Executive Officer, John Dempsey Hospital, and Dr. Pramod Srivastava during his recent visit to UConn Health. (Janine Gelineau/UConn Health photo)

U.S. Sen. Richard Blumenthal recently met with UConn Health officials to discuss the important role data registries will play in the future of health care in Connecticut and across the country. All health care stakeholders, organizations, providers, insurers, and patients, have questions related to the medical care they are receiving or providing. The answers to these questions should be accessible in registries providing patients the data they need to make informed health care decisions and allowing health care organizations to report and benchmark their quality measures against other providers.

“Beyond participation in national data registries, it will be the changes in clinical practice, based on the rigorous data analysis that will define meaningful improvements in health care delivery. The commitment to total outcome transparency will be anxiety provoking at first but, in the end, it will be the ‘quality tide’ that raises all boats: improved patient outcomes, optimal practitioner performance, and value-added, highest quality care that third party payers will demand,” says Dr. Stephen Lahey, chief of cardiothoracic surgery, and vice chair of quality improvement at UConn Health.

U.S. Senator Richard Blumenthal with L to R: Dr. Pramod Srivastava, Blumenthal, Anne Diamond, and Dr. Stephen Laheh
Dr. Pramod Srivastava with U.S. Sen. Blumenthal, Anne Diamond, and Dr. Stephen Lahey. (Janine Gelineau/UConn Health photo)

During his visit, Blumenthal also toured the research lab of Dr. Pramod Srivastava, professor of immunology and medicine and director of the Carole and Ray Neag Comprehensive Cancer Center. Blumenthal learned about Srivastava’s recently approved FDA genomics-driven clinical study for patients with advanced stage ovarian cancer, in which personalized cancer vaccines will be developed for each patient.